Research Report of Accomplishments
These reports highlight the depth and breadth of Beaumont’s academic excellence. We extend our congratulations and appreciation to the many investigators who have contributed these extraordinary achievements while providing outstanding medical care to our patients. We look forward to continuing research excellence and productivity as Beaumont enters an exciting new phase of academic development.
For more than 45 years, researchers at Beaumont have helped to bring new technologies, new treatments and new medications into the practice of medicine and have helped to move the standard of care forward to improve the safety and quality of medical care for patients locally, nationally and internationally. The greatest reward from these achievements is the realization that patients’ lives are improved and enriched because of the outstanding research carried out by the Beaumont physicians and staff.
These reports of accomplishment reflect the well established national and international reputation achieved by some of our research programs, including, but not limited to:
- cardiovascular medicine
- radiation oncology
- medical oncology (hem/onc)
- emergency medicine
Outstanding biomedical research is a major component of the excellent reputation of Beaumont Health System as an academic medical center. The Board of Directors at Beaumont made a commitment several decades ago to strengthen Beaumont as an academic institution through growth and support of graduate medical education, the hiring of full-time physicians with conspicuous excellence in research, and committed support of ongoing research activities of key programs. This commitment has helped to forge the reputation of Beaumont as a leading academic medical center, with recognition by U.S. News & World Report, a distinction that places Beaumont in the forefront of medicine in the U.S.
OUWB School of Medicine
For the Oakland University William Beaumont School of Medicine, strong undergraduate medical education requires faculty committed to research and a broad, excellent program of graduate medical education. The ACGME (Accreditation Council on Graduate Medical Education) is steadily increasing the requirements for excellence in both faculty research achievement and resident/fellow research training in order to maintain full accreditation for residency and fellowship programs. The Board for Accrediting Level 1 Trauma Center status, presently achieved by Beaumont, Royal Oak, now requires high productivity of peer-reviewed publications in recognized journals by participating faculty. The LCME (Liaison Committee on Medical Education), the accrediting organization for medical schools in the U.S. and Canada, requires the presence of biomedical research activities that can provide both basic sciences and clinical research opportunities for medical students. The formation of a new medical school provides further impetus to enhance biomedical research at both Beaumont and Oakland University, to integrate research activities between the two institutions, and to initiate new programs, centers and collaborative projects shared by both institutions. Beaumont and Oakland University already have several areas of long standing ongoing research collaboration, and have initiated a formal program of small grant support for collaborative studies. These organizations also have formed the Institute for Stem Cell Research and Regenerative Medicine.
Beaumont research is heavily oriented towards clinical translational research, investigating new treatments, pharmaceuticals, medical devices and scientific approaches aimed at enhancing the excellence and safety of patient care. Beaumont has a robust program of clinical trials, numbering over 1,100 trials with over 82,000 enrolled subjects. Beaumont’s clinical services are superb, providing the standard upon which new and innovative research is built. Beaumont’s volume of patients served, combined with the excellence of clinical care, provides a striking opportunity to develop new treatments.
Core Molecular Laboratory
The Research Institute has built a full service Core Molecular Laboratory (The Erb Family Core Molecular and Genetics Laboratory) with modern technologies in genomics, proteomics, molecular biology, cell sorting, confocal microscopy and other sophisticated technologies, along with the necessary technical support, in order to provide the research tools for clinical investigators to further their research activities. The Research Institute also has established a BioBank for tissue and serum collection, storage, and analysis, available for clinical translational research across the entire Beaumont academic spectrum. The initial emphasis of the Core Molecular Laboratory and the BioBank is research on molecular biomarker discovery, particularly related to early detection of disease, disease risk, and the selection of appropriate therapies. The Research Institute also has strengthened grant writing support, assistance with identifying sources of funding and grant opportunities, and other support services, with a renewed emphasis on a commitment to helping Beaumont physicians carry out excellent research. The success of our commitment to excellent service and patient safety is shown by our receipt of full accreditation of our human research protection program by AAHRPP (Association for Accreditation of Human Research Protection Programs) on the first submission.